Cargando…

Aspirin or Ticagrelor in Staphylococcus aureus Infective Endocarditis: Where Do We Stand?

Infective endocarditis is a challenging disease with a high mortality and morbidity rate. Antibiotic prophylaxis is currently recommended in high-risk infective endocarditis patients. However, the use of antibiotics faces the challenge of a low efficacy and contributes further to the emerging infect...

Descripción completa

Detalles Bibliográficos
Autores principales:	Leeten, Kirsten, Jacques, Nicolas, Lancellotti, Patrizio, Oury, Cécile
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Cell and Developmental Biology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8529053/ https://www.ncbi.nlm.nih.gov/pubmed/34692677 http://dx.doi.org/10.3389/fcell.2021.716302

Ejemplares similares

Fluoroquinolone Therapy in Staphylococcus aureus Infections: Where Do We Stand?
por: Gade, Neeta D, et al.
Publicado: (2013)

Aspirin Effect on Staphylococcus aureus—Platelet Interactions During Infectious Endocarditis
por: Hannachi, Nadji, et al.
Publicado: (2019)

Identification of Methicillin-Resistant Staphylococcus Aureus From Methicillin-Sensitive Staphylococcus Aureus and Molecular Characterization in Quanzhou, China
por: Bai, Zhimin, et al.
Publicado: (2021)

The Role of p21-Activated Kinases in Cancer and Beyond: Where Are We Heading?
por: Liu, Hui, et al.
Publicado: (2021)

The Dual Role of Neutrophils in Inflammatory Bowel Diseases
por: Wéra, Odile, et al.
Publicado: (2016)

Editorial: From Biology to Clinical Management: An Update on Aortic Valve Disease
por: Oury, Cécile, et al.
Publicado: (2019)

Where Do We Stand?
Publicado: (1891)

Cancer: Where We Stand
Publicado: (1951)

Joint Discussion – Where we stand and where we want to go
por: CERN. Geneva
Publicado: (2013)

Joint Discussion – Where we stand and where we want to go
por: CERN. Geneva
Publicado: (2013)

Neutrino Masses and Mixing: Where We Stand and Where We are Going
por: Gonzalez-Garcia, M.C.
Publicado: (2002)

Alzheimer’s disease and infections, where we stand and where we go
por: Monastero, Roberto, et al.
Publicado: (2014)

Addictive behaviors: where do we stand, and where are we going?
por: Thibaut, Florence, et al.
Publicado: (2017)

A Clinically Selected Staphylococcus aureus clpP Mutant Survives Daptomycin Treatment by Reducing Binding of the Antibiotic and Adapting a Rod-Shaped Morphology
por: Xu, Lijuan, et al.
Publicado: (2023)

Gravity: where do we stand ?
por: Peron, Roberto, et al.
Publicado: (2016)

Where we stand with the real superworld
por: Zichichi, Antonino
Publicado: (1993)

Correcting LEP: where we stand
por: Kleiss, R H
Publicado: (1989)

Recurrent Glioblastoma: Where we stand
por: Roy, Sanjoy, et al.
Publicado: (2015)

Corneal xenotransplantation: Where are we standing?
por: Yoon, Chang Ho, et al.
Publicado: (2021)

THREE-DIMENSIONAL PRINTING IN ORTHOPEDICS: WHERE WE STAND AND WHERE WE ARE HEADING
por: EJNISMAN, LEANDRO, et al.
Publicado: (2021)

Biomarkers for Alzheimer’s Disease: Where Do We Stand and Where Are We Going?
por: Villa, Chiara
Publicado: (2020)

Sympathetic Modulation in Cardiac Arrhythmias: Where We Stand and Where We Go
por: Chung, Wei-Hsin, et al.
Publicado: (2023)

Advances in Pathophysiology of Calcific Aortic Valve Disease Propose Novel Molecular Therapeutic Targets
por: Hulin, Alexia, et al.
Publicado: (2018)

Staphylococcus aureus Infection Influences the Function of Intestinal Cells by Altering the Lipid Raft-Dependent Sorting of Sucrase–Isomaltase
por: Mergani, AhmedElmontaser, et al.
Publicado: (2021)

The Role of Iron in Staphylococcus aureus Infection and Human Disease: A Metal Tug of War at the Host—Microbe Interface
por: van Dijk, Madeleine C., et al.
Publicado: (2022)

Prosthetic Aortic Valves: Challenges and Solutions
por: Musumeci, Lucia, et al.
Publicado: (2018)

Novel radionuclides for use in Nuclear Medicine in Europe: where do we stand and where do we go?
por: Radzina, Maija, et al.
Publicado: (2023)

ColVI myopathies: where do we stand, where do we go?
por: Allamand, Valérie, et al.
Publicado: (2011)

The Role of Angiogenesis in Haemophilic Arthropathy: Where Do We Stand and Where Are We Going?
por: Agapidou, Alexandra, et al.
Publicado: (2016)

Scoping review of brucellosis in Cameroon: Where do we stand, and where are we going?
por: Laine, Christopher G., et al.
Publicado: (2020)

Application of molecular SERS nanosensors: where we stand and where we are headed towards?
por: Jahn, Izabella J., et al.
Publicado: (2020)

Late Sodium Current of the Heart: Where Do We Stand and Where Are We Going?
por: Horváth, Balázs, et al.
Publicado: (2022)

Where are all the egg genes?
por: Maniates, Katherine A., et al.
Publicado: (2023)

Stimulator of Interferon Genes (STING) Promotes Staphylococcus aureus-Induced Extracellular Traps Formation via the ROS-ERK Signaling Pathway
por: Liu, Zhen-Zhen, et al.
Publicado: (2022)

Can Blood Biomarkers Help Predicting Outcome in Transcatheter Aortic Valve Implantation?
por: Oury, Cécile, et al.
Publicado: (2018)

Pixel Detectors ... where do we stand?
por: Wermes, Norbert
Publicado: (2019)

Laser accelerators : where do we stand
por: Lawson, J D
Publicado: (1985)

Renormalization schemes: where do we stand?
por: Ward, B F L
Publicado: (1990)

CHRONIC AUTOIMMUNE URTICARIA: WHERE WE STAND?
por: Goh, C L, et al.
Publicado: (2009)

Barrett's Esophagus: Where Do We Stand?
por: Al Madi, Majid A.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_qqig4mrpqm3rjt9sf5krae5moq